Mid-Size Pharmaceutical Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Prescription and Over-the-Counter), Drug Development Type (In-House and Outsource), Formulation (Tablets and Capsules, Injectables, Sprays, and Other formulatio

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,550	203 Pages	The Insight Partners	June, 2022	TIP17311594

Best Price Guarantee
Price	from $4,550
Length	203 Pages
Publisher	The Insight Partners
Published Date	June, 2022
SKU	TIP17311594

Mid-Size Pharmaceutical Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Prescription and Over-the-Counter), Drug Development Type (In-House and Outsource), Formulation (Tablets and Capsules, Injectables, Sprays, and Other formulations), and Therapy Class (Cardiovascular Diseases, Pain Management, Diabetes, Cancer, and Other Conditions)

The mid-size pharmaceutical market is expected to grow from US$ 6,51,349.9 million in 2021 to US$ 10,00,584.3 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028.

The increasing prevalence of chronic diseases and the rising number of products launches & approvals drive the market growth. However, cutthroat competition among market players hampers the mid-size pharmaceutical market growth.

Revenue, therapy area, R&D expenditure, and reach are among the critical segments of the global pharmaceutical industry. Mid-size pharmaceutical is among the three categories of the pharmaceutical industry. It emphasizes the development of generic drugs and the development of rare disease therapies. The mid-sized pharmaceutical companies have their revenue in the range of US$ 1 billion to US$ 10 billion. The increasing prevalence of chronic diseases, rapidly rising elderly population, and the surging number of products launches & approvals is expected to aid the mid-size pharmaceutical market growth.

The aging population and changing social behavior contribute to the steady increase in common and costly long-term health problems. With the accelerating urbanization, people are adopting a sedentary lifestyle, which boosts the rates of obesity and cases of illnesses, such as diabetes. According to the World Health Organization, the prevalence of chronic diseases is projected to increase by 57% by 2026. Emerging markets will be hit hardest, as population growth is expected to be the strongest in developing countries. Increasing demand for health care systems due to the rising incidence of chronic illnesses has become a major concern.

Diabetes is one of the biggest global health problems of the 21st century. Every year, many people develop this condition, causing life-changing complications. According to the International Diabetes Federation (IDF), the number of people with diabetes in North America was about 46 million in 2019 and is projected to increase to 62 million by 2045. The increase in disease prevalence would be about 35% during the predicted period. Pandemics such as COVID-19, have tested the rate at which infections unfold throughout the globe. Pandemics exert periodic and enormous disruptive strains on fitness systems. Healthcare establishments across the world want to be geared up to collectively comprise outbreaks once they occur. Thus, the increasing prevalence of chronic disorders boosts the mid-size pharmaceutical market growth.

Based on type, the mid-size pharmaceutical market is segmented into prescription and over-the-counter. In 2021, the over-the-counter segment held a larger market share. Furthermore, it is expected to register a higher CAGR of 6.7% during the forecast period.

Based on drug development type, the mid-size pharmaceutical market is segmented into in-house and outsource. In 2021, the outsource segment held a larger share of the market. It is expected to register a higher CAGR of 6.7% during 2021–2028.

Based on formulation, the mid-size pharmaceutical market is segmented into tablets & capsules, injectables, sprays, and other formulations. In 2021, the tablets & capsules segment held the largest share of the market. It is expected to register the highest CAGR of 7.1% during 2021–2028.

Based on therapy area, the mid-size pharmaceutical market is segmented into cardiovascular diseases, pain management, diabetes, cancer, and other conditions. In 2021, the diabetes segment held the largest share of the market. On the other hand, the cancer segment is expected to register the highest CAGR of 7.0% during 2021–2028.

The World Health Organization (WHO); Economic Co-operation and Development (OECD); Brazilian Ministry of Economy; GLOBOCAN; Centers for Disease Control and Prevention (CDC); United Nations International Children's Emergency Fund (UNICEF); and US Census Bureau are among the major secondary sources referred to while preparing the report on the mid-size pharmaceutical market.

Reason to buys

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the mid-size pharmaceutical market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global mid-size pharmaceutical market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction: 1.1 Scope of the Study; 1.2 The Insight Partners Research Report Guidance; 1.3 Market Segmentation; 1.3.1 Global Mid-Size Pharmaceutical – By Type; 1.3.2 Global Mid-Size Pharmaceutical – By Drug Development Type; 1.3.3 Global Mid-Size Pharmaceutical – By Formulation; 1.3.4 Global Mid-Size Pharmaceutical – By Therapy Area; 1.3.5 Global Mid-Size Pharmaceutical – By Geography
2. Key Takeaways
3. Research Methodology: 3.1 Coverage; 3.2 Secondary Research; 3.3 Primary Research
4. Global Mid-Size Pharmaceutical – Market Landscape: 4.1 Overview; 4.2 PEST Analysis; 4.2.1 North America – PEST Analysis; 4.2.2 Europe – PEST Analysis; 4.2.3 Asia Pacific – PEST Analysis; 4.2.4 Middle East & Africa – PEST Analysis; 4.2.5 South & Central America – PEST Analysis; 4.3 Expert Opinion
5. Mid-Size Pharmaceutical Market – Key Market Dynamics: 5.1 Market Drivers; 5.1.1 Increasing Prevalence of Chronic Disorders; 5.1.2 Increasing Product Approval and Launches; 5.2 Market Restraints; 5.2.1 Cutthroat Competition among Market Players; 5.3 Market Opportunities; 5.3.1 Rising Number of Healthcare Start-ups; 5.4 Future Trends; 5.4.1 Greater Focus on R&D; 5.5 Impact Analysis
6. Mid-Size Pharmaceutical Market– Global Analysis: 6.1 Global Mid-Size Pharmaceutical Market Revenue Forecast And Analysis; 6.1.1 Global Mid-Size Pharmaceutical Market Revenue Forecast And Analysis; 6.1.2 Global Mid-Size Pharmaceutical Market – Market Potential Analysis, By Region; 6.2 Market Positioning Analysis Of Key Players In Mid-Size Pharmaceutical Market; 6.2.1 Company Analysis; 6.2.2 Growth Strategy Analysis; 6.2.3 Performance Of Key Players; 6.2.3.1 Regeneron Pharmaceuticals, Inc.; 6.2.3.2 DAIICHI SANKYO COMPANY LIMITED
7. Global Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028– by Type: 7.1 Overview; 7.2 Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028); 7.3 Prescription; 7.3.1 Overview; 7.3.2 Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 7.4 Over-the-Counter (OTC); 7.4.1 Overview; 7.4.2 Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
8. Mid-Size Pharmaceutical Market Analysis – By Drug Development Type: 8.1 Overview; 8.2 Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028); 8.3 In-House; 8.3.1 Overview; 8.3.2 In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 8.4 Outsource; 8.4.1 Overview; 8.4.2 Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9. Mid-Size Pharmaceutical Market – By Formulation: 9.1 Overview; 9.2 Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%); 9.3 Tablets and Capsules; 9.3.1 Overview; 9.3.2 Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 9.4 Injectables; 9.4.1 Overview; 9.4.2 Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 9.5 Sprays; 9.5.1 Overview; 9.5.2 Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 9.6 Other Formulations; 9.6.1 Overview; 9.6.2 Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10. Mid-Size Pharmaceutical Market – By Therapy Class: 10.1 Overview; 10.2 Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%); 10.3 Cardiovascular Diseases; 10.3.1 Overview; 10.3.2 Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 10.4 Pain Management; 10.4.1 Overview; 10.4.2 Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 10.5 Diabetes; 10.5.1 Overview; 10.5.2 Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 10.6 Cancer; 10.6.1 Overview; 10.6.2 Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 10.7 Other Diseases; 10.7.1 Overview; 10.7.2 Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11. Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 – Geographical Analysis: 11.1 North America: Mid-Size Pharmaceutical Market; 11.1.1 Overview; 11.1.2 North America: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.3 North America: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (US$ Million); 11.1.4 North America: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (US$ Million); 11.1.5 North America: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (US$ Million); 11.1.6 North America: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (US$ Million); 11.1.7 North America: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%); 11.1.7.1 US: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.7.1.1 Overview; 11.1.7.1.2 US: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.7.1.3 US: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (US$ Million); 11.1.7.1.4 US: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (US$ Million); 11.1.7.1.5 US: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (US$ Million); 11.1.7.1.6 US: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (US$ Million); 11.1.7.2 Canada: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.7.2.1 Overview; 11.1.7.2.2 Canada: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.7.2.3 Canada: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (US$ Million); 11.1.7.2.4 Canada: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (US$ Million); 11.1.7.2.5 Canada: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (US$ Million); 11.1.7.2.6 Canada: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (US$ Million); 11.1.7.3 Mexico: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.7.3.1 Overview; 11.1.7.3.2 Mexico: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.1.7.3.3 Mexico: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (US$ Million); 11.1.7.3.4 Mexico: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (US$ Million); 11.1.7.3.5 Mexico: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (US$ Million); 11.1.7.3.6 Mexico: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (US$ Million); 11.2 Europe: Mid-Size Pharmaceutical Market; 11.2.1 Overview; 11.2.2 Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.2.3 Europe: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); 11.2.4 Europe: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); 11.2.4.1 Europe: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.2.4.2 Europe: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); 11.2.5 Europe: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%); 11.2.5.1 Germany: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.2.5.1.1 Overview; 11.2.5.1.2 Germany: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.2.5.1.3 Germany: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); 11.2.5.1.4 Germany: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); 11.2.5.1.5 Germany: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.2.5.1.6 Germany: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); 11.2.5.2 France: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.2.5.2.1 Overview; 11.2.5.2.2 France: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.2.5.2.3 France: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); 11.2.5.2.4 France: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); 11.2.5.2.5 France: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.2.5.2.6 France: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); 11.2.5.3 UK: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.2.5.3.1 Overview; 11.2.5.3.2 UK: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.2.5.3.3 UK: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); 11.2.5.3.4 UK: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); 11.2.5.3.5 UK: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.2.5.3.6 UK: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); 11.2.5.4 Italy: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.2.5.4.1 Overview; 11.2.5.4.2 Italy: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.2.5.4.3 Italy: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); 11.2.5.4.4 Italy: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); 11.2.5.4.5 Italy: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.2.5.4.6 Italy: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); 11.2.5.5 Spain: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.2.5.5.1 Overview; 11.2.5.5.2 Spain: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.2.5.5.3 Spain: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); 11.2.5.5.4 Spain: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); 11.2.5.5.5 Spain: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.2.5.5.6 Spain: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); 11.2.5.6 Rest of Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.2.5.6.1 Overview; 11.2.5.6.2 Rest of Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million); 11.2.5.6.3 Rest of Europe: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); 11.2.5.6.4 Rest of Europe: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); 11.2.5.6.5 Rest of Europe: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.2.5.6.6 Rest of Europe: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); 11.3 Asia Pacific: Mid-Size Pharmaceutical Market; 11.3.1 Overview; 11.3.2 Asia Pacific: Mid-Size Pharmaceutical Market - Revenue and Forecast to 2028 (USD Million); 11.3.3 Asia Pacific: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million); 11.3.3.1 Asia Pacific: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019–2028 (USD Million); 11.3.3.2 Asia Pacific: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million); 11.3.4 Asia Pacific: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million); 11.3.5 Asia Pacific: Mid-Size Pharmaceutical Market, by Country, 2022 & 2028 (%); 11.3.5.1 China: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.3.5.1.1 China: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.3.5.1.2 China: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million); 11.3.5.1.3 China: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019–2028 (USD Million); 11.3.5.1.4 China: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million); 11.3.5.1.5 China: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million); 11.3.5.2 Japan: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.3.5.2.1 Japan: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.3.5.2.2 Japan: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million); 11.3.5.2.3 Japan: Mid-Size Pharmaceutical Market, By Drug Development Type , 2019–2028 (USD Million); 11.3.5.2.4 Japan: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million); 11.3.5.2.5 Japan: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million); 11.3.5.3 India: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.3.5.3.1 India: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.3.5.3.2 India: Mid-Size Pharmaceutical Market, By Type , 2019–2028 (USD Million); 11.3.5.3.3 India: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019–2028 (USD Million); 11.3.5.3.4 India: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million); 11.3.5.3.5 India: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million); 11.3.5.4 Australia: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.3.5.4.1 Australia: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.3.5.4.2 Australia: Mid-Size Pharmaceutical Market , By Type , 2019–2028 (USD Million); 11.3.5.4.3 Australia: Mid-Size Pharmaceutical Market , By Drug Development Type , 2019–2028 (USD Million); 11.3.5.4.4 Australia: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million); 11.3.5.4.5 Australia: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million); 11.3.5.5 South Korea: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.3.5.5.1 South Korea: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.3.5.5.2 South Korea: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million); 11.3.5.5.3 South Korea: Mid-Size Pharmaceutical Market, By Drug Development Type , 2019–2028 (USD Million); 11.3.5.5.4 South Korea: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million); 11.3.5.5.5 South Korea: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million); 11.3.5.6 Rest of Asia Pacific: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.3.5.6.1 Rest of Asia Pacific: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.3.5.6.2 Rest of Asia Pacific: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million); 11.3.5.6.3 Rest of Asia Pacific: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019–2028 (USD Million); 11.3.5.6.4 Rest of Asia Pacific: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million); 11.3.5.6.5 Rest of Asia Pacific: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million); 11.4 Middle East & Africa Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028; 11.4.1 Overview; 11.4.2 Middle East & Africa Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million); 11.4.3 Middle East & Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type(US$ Million); 11.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Drug Development Type (US$ Million); 11.4.4.1 Middle East & Africa: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.4.4.2 Middle East & Africa: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); 11.4.5 Middle East & Africa Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Country (%); 11.4.5.1 UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million); 11.4.5.1.1 Overview; 11.4.5.1.2 UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million); 11.4.5.1.3 UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million); 11.4.5.1.4 UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million); 11.4.5.1.5 UAE: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.4.5.1.6 UAE: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); 11.4.5.2 Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million); 11.4.5.2.1 Overview; 11.4.5.2.2 Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million); 11.4.5.2.3 Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million); 11.4.5.2.4 Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million); 11.4.5.2.5 Saudi Arabia: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.4.5.2.6 Saudi Arabia: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); 11.4.5.3 South Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million); 11.4.5.3.1 Overview; 11.4.5.3.2 South Africa Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million); 11.4.5.3.3 South Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million); 11.4.5.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million); 11.4.5.3.5 South Africa: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.4.5.3.6 South Africa: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); 11.4.5.4 Rest of Middle East and Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million); 11.4.5.4.1 Overview; 11.4.5.4.2 Rest of Middle East and Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million); 11.4.5.4.3 Rest of Middle East & Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million); 11.4.5.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million); 11.4.5.4.5 Rest of Middle East and Africa: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.4.5.4.6 Rest of Middle East and Africa: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); 11.5 South & Central America: Mid-Size Pharmaceutical Market; 11.5.1 Overview; 11.5.2 South and Central America: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.5.3 South and Central America: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (USD Million); 11.5.4 South and Central America: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (USD Million); 11.5.5 South and Central America: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (USD Million); 11.5.6 South and Central America: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (USD Million); 11.5.7 South and Central America: Mid-Size Pharmaceutical Market, by country, 2021 & 2028 (%); 11.5.7.1 Brazil: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.5.7.1.1 Brazil: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.5.7.1.2 Brazil: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (USD Million); 11.5.7.1.3 Brazil: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (USD Million); 11.5.7.1.4 Brazil: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (USD Million); 11.5.7.1.5 Brazil: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (USD Million); 11.5.7.2 Argentina: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.5.7.2.1 Argentina: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.5.7.2.2 Argentina: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (USD Million); 11.5.7.2.3 Argentina: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (USD Million); 11.5.7.2.4 Argentina: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (USD Million); 11.5.7.2.5 Argentina: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (USD Million); 11.5.7.3 Rest of South and Central America: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million); 11.5.7.3.1 Rest of South and Central America: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028(USD Million); 11.5.7.3.2 Rest of South and Central America: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (USD Million); 11.5.7.3.3 Rest of South and Central America: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (USD Million); 11.5.7.3.4 Rest of South and Central America: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (USD Million); 11.5.7.3.5 Rest of South and Central America: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Mid-Size Pharmaceutical Market: 12.1 North America: Impact Assessment of COVID-19 Pandemic; 12.2 Europe: Impact Assessment of COVID-19 Pandemic; 12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic; 12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic; 12.5 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Mid-Size Pharmaceutical Market–Industry Landscape: 13.1 Overview; 13.2 Growth Strategies Done by the Companies in the Market, (%); 13.3 Organic Developments; 13.3.1 Overview; 13.4 Inorganic Developments; 13.4.1 Overview
14. Company Profiles: 14.1 DAIICHI SANKYO COMPANY LIMITED; 14.1.1 Key Facts; 14.1.2 Business Description; 14.1.3 Products and Services; 14.1.4 Financial Overview; 14.1.5 SWOT Analysis; 14.1.6 Key Developments; 14.2 Eisai Co., Ltd.; 14.2.1 Key Facts; 14.2.2 Business Description; 14.2.3 Products and Services; 14.2.4 Financial Overview; 14.2.5 SWOT Analysis; 14.2.6 Key Developments; 14.3 Bausch Health Companies Inc.; 14.3.1 Key Facts; 14.3.2 Business Description; 14.3.3 Products and Services; 14.3.4 Financial Overview; 14.3.5 SWOT Analysis; 14.3.6 Key Developments; 14.4 Regeneron Pharmaceuticals, Inc; 14.4.1 Key Facts; 14.4.2 Business Description; 14.4.3 Products and Services; 14.4.4 Financial Overview; 14.4.5 SWOT Analysis; 14.4.6 Key Developments; 14.5 Sun Pharmaceutical Industries Ltd; 14.5.1 Key Facts; 14.5.2 Business Description; 14.5.3 Products and Services; 14.5.4 Financial Overview; 14.5.5 SWOT Analysis; 14.5.6 Key Developments; 14.6 Alexion Pharmaceuticals, Inc.; 14.6.1 Key Facts; 14.6.2 Business Description; 14.6.3 Products and Services; 14.6.4 Financial Overview; 14.6.5 SWOT Analysis; 14.6.6 Key Developments; 14.7 Mallinckrodt; 14.7.1 Key Facts; 14.7.2 Business Description; 14.7.3 Products and Services; 14.7.4 Financial Overview; 14.7.5 SWOT Analysis; 14.7.6 Key Developments; 14.8 Endo Pharmaceuticals Inc.; 14.8.1 Key Facts; 14.8.2 Business Description; 14.8.3 Products and Services; 14.8.4 Financial Overview; 14.8.5 SWOT Analysis; 14.8.6 Key Developments; 14.9 Les Laboratories Servier; 14.9.1 Key Facts; 14.9.2 Business Description; 14.9.3 Products and Services; 14.9.4 Financial Overview; 14.9.5 SWOT Analysis; 14.9.6 Key Developments; 14.10 UCB S.A.; 14.10.1 Key Facts; 14.10.2 Business Description; 14.10.3 Products and Services; 14.10.4 Financial Overview; 14.10.5 SWOT Analysis; 14.10.6 Key Developments
15. Appendix: 15.1 About The Insight Partners; 15.2 Glossary of Terms
LIST OF TABLES: Table 1. North America Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 2. North America Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 3. North America Mid-Size Pharmaceutical Market, by Formulation– Revenue and Forecast to 2028 (US$ Million); Table 4. North America Mid-Size Pharmaceutical Market, by Therapy Area– Revenue and Forecast to 2028 (US$ Million); Table 5. US Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 6. US Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 7. US Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); Table 8. US Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 9. Canada: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 10. Canada Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 11. Canada Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); Table 12. Canada Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 13. Mexico: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 14. Mexico Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 15. Mexico Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); Table 16. Mexico Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 17. Europe: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 18. Europe: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 19. Europe: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); Table 20. Europe: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 21. Germany: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 22. Germany: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 23. Germany: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); Table 24. Germany: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 25. France: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 26. France: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 27. France: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); Table 28. France: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 29. UK: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 30. UK: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 31. UK: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); Table 32. UK: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 33. Italy: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 34. Italy: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 35. Italy: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); Table 36. Italy: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 37. Spain: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 38. Spain: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 39. Spain: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); Table 40. Spain: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 41. Rest of Europe: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million); Table 42. Rest of Europe: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million); Table 43. Rest of Europe: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million); Table 44. Rest of Europe: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 45. Asia Pacific: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (US$ Million); Table 46. Asia Pacific: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and forecast to 2028 (US$ Million); Table 47. Asia Pacific: Mid-Size Pharmaceutical Market, By Formulation – Revenue and forecast to 2028 (US$ Million); Table 48. Asia Pacific: Mid-Size Pharmaceutical Market, By Therapy Area – Revenue and Forecast to 2028 (US$ Million); Table 49. China: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (US$ Million); Table 50. China: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and forecast to 2028 (US$ Million); Table 51. China: Mid-Size Pharmaceutical Market, By Formulation – R